Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial, Mundipharma Pty Limited, CON-650
Product name
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Sponsor name
Mundipharma Pty Limited
Consent start
Consent no.
CON-650
Standard
Therapeutic Goods Order No. 92 '“ Standard for labels of non-prescription medicines
Non-compliance with standard
The products do not conform with the Therapeutic Goods Order No. 92 '“ Standard
for labels of non-prescription medicines but are fully compliant with all
requirements of the Therapeutic Goods Order No. 69 '“ General requirements for
labels for medicines
Therapeutic product type
Over-the-counter medicines